EOM Pharmaceutical Holdings Inc (IMUC)
0.1979
+0.02
(+12.16%)
USD |
OTCM |
Apr 19, 15:28
EOM Pharmaceutical Holdings Cash from Operations (TTM): -10.93M for June 30, 2018
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
June 30, 2018 | -10.93M |
March 31, 2018 | -12.20M |
December 31, 2017 | -16.67M |
September 30, 2017 | -15.48M |
June 30, 2017 | -18.19M |
March 31, 2017 | -20.58M |
December 31, 2016 | -19.86M |
September 30, 2016 | -21.94M |
June 30, 2016 | -23.33M |
March 31, 2016 | -21.34M |
December 31, 2015 | -19.04M |
September 30, 2015 | -15.33M |
June 30, 2015 | -11.53M |
March 31, 2015 | -10.37M |
December 31, 2014 | -9.937M |
September 30, 2014 | -10.56M |
June 30, 2014 | -9.986M |
March 31, 2014 | -9.194M |
December 31, 2013 | -8.787M |
September 30, 2013 | -9.247M |
June 30, 2013 | -9.609M |
March 31, 2013 | -11.01M |
December 31, 2012 | -12.38M |
September 30, 2012 | -10.97M |
Date | Value |
---|---|
June 30, 2012 | -10.46M |
March 31, 2012 | -8.427M |
December 31, 2011 | -6.384M |
September 30, 2011 | -5.540M |
June 30, 2011 | -5.252M |
March 31, 2011 | -5.112M |
December 31, 2010 | -4.254M |
September 30, 2010 | -3.581M |
June 30, 2010 | -2.663M |
March 31, 2010 | -2.303M |
December 31, 2009 | -2.152M |
September 30, 2009 | -2.306M |
June 30, 2009 | -2.176M |
March 31, 2009 | -1.881M |
December 31, 2008 | -1.945M |
September 30, 2008 | -1.847M |
June 30, 2008 | -1.474M |
March 31, 2008 | -1.245M |
December 31, 2007 | -0.912M |
September 30, 2007 | -0.8655M |
June 30, 2007 | -0.8111M |
March 31, 2007 | -0.6596M |
December 31, 2006 | -0.5277M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
CEL-SCI Corp | -23.07M |
AIM ImmunoTech Inc | -21.27M |
IGC Pharma Inc | -6.19M |
NovaBay Pharmaceuticals Inc | -4.131M |
Protalix BioTherapeutics Inc | -1.318M |